Genetics and Breast Cancer Risk

http://envirocancer.cornell.edu/Bibliography/Genetics/bib.genetic.cfm

Skip to main content

New

Program

Learning

Resources

Events

Maps

&

Stats

Research

Resources

BCERF

Research

Genetics and Breast Cancer Risk Bibliography

This bibliography is provided as a service to our readers. It is compiled from the entries in the BCERF Environmental Risk Factors Bibliographic Database. This bibliography is arranged topically. The topics include: Basic Reviews on the Origins of Cancer Reviews on Genetics, Tumor Suppressor Genes and Breast Cancer Risk Commentaries and Editorials on Genetics and Breast Cancer Reviews on p53 and Breast Cancer Risk BRCA1, and BRCA2; Breast Cancer Susceptibility Genes Human Studies on BRCA Mutations and Cancer Risk Commentaries on Genetic Testing and Breast Cancer Risk New Breast Cancer Tumor Suppressor Genes Environmental Carinogenesis and Molecular Epidemiology Basic Reviews on the Origins of Cancer Ruoslahti, E. (1996). How cancer spreads. Scientific American, 72-77. Weinberg, R. A. (1996). How cancer arises. Scientific American, 62-70.

Back to the top Reviews on Genetics, Tumor Suppressor Genes and Breast Cancer Risk Barnes, D. M., and Camplejohn, R. S. (1996). P53, Apoptosis, and Breast Cancer. Journal of Mammary Gland Biology and Neoplasia 1, 163-175. Begley, S. (1996). The cancer killer. In Newsweek, pp. 42-47. Biéche, I., and Lidereau, R. (1995). Genetic alternations in breast cancer. Genes, Chromosomes, and Cancer 14, 227-251. Bonilla, F., Provencio, M., and Cubedo, R. (1996). BRCA1 and BRCA2: Breast and ovarian cancer susceptibility genes. Oncologia 19, 33-39. Cannon-Albright, L. A., and Skolnick, M. H. (1996). The genetics of familal breast cancer. Senimars in Oncology 23(Suppl 2), 1-5. Cooper, G. M. (1995). Tumor suppressor genes in human neoplasms. In Oncogenes, Chapter 10 (Boston: Jones and Bartlett), pp. 145-151. Cox, L. A., Chen, G., and Lee, E. Y.-H. P. (1994). Tumor suppressor genes and their roles in breast cancer. Breast Cancer Research and Treatment 32, 19-38. Dairkee, S. H., and Smith, H. S. (1996). Genetic analysis of breast cancer progression. Journal of Mammary Gland Biology and Neoplasia 1, 139-151.

1 of 5

2/20/10 4:45 PM

Genetics and Breast Cancer Risk

http://envirocancer.cornell.edu/Bibliography/Genetics/bib.genetic.cfm

Fearon, E. R. (1997). Human cancer syndromes: Clues to the origin and nature of cancer. Science 278, 1043-1050. Harris, C. C. (1996). p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environmental Health Perspectives 104, 435-439. Kinzler, K. W., and Vogelstein, B. (1997). Gatekeepers and caretakers. Nature 386, 761 - 763. Lee, E.Y.-H. P. (1995). Tumor suppressor genes and their alterations in breast cancer. Seminars in Cancer Biology 6, 119-125. Marx, J. (1997). Possible function found for breast cancer genes. Science 276, 531-532. Preston, R. J. (1996). Genetic susceptibility and sensitivity to cancer. CIIT Activities 16, 1-6. Radford, D. M., and Zehnbauer, B. A. (1996). Inherited breast cancer. Surgical Clinics of North America 76, 205-217. Semenza, J. C., and Weasel, L. H. (1997). Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environmental Health Perspectives 105(Suppl 1), 155-163. Stratton, M. R. (1996). Recent advances in understanding of genetic susceptibility to breast cancer. Human Molecular Genetics 5, 1515-1519. Weinberg, R. A. (1996). How cancer arises. Scientific American, 62-70. Commentaries and Editorials on Genetics and Breast Cancer Baram, M. (1997). The laws of genetics (commentary). Environmental Health Perspectives 105, 488-491. Collins, F. S. (1996). BRCA1 - lots of mutations, lots of dilemmas [editorial]. New England Journal of Medicine 334, 186-188. Healy, B. (1997). BRCA Genes-Bookmaking, fortunetelling, and medical care (editorial). New England Journal of Medicine 336, 1448-1449. Hoffman, M. (1996). Desperately seeking BRCA1 [editorial]. American Scientist 84, 535-536. Kahn, P. (1996). Coming to grips with genes and risk. Science 274, 496-498. Kolata, G. (1996). Discovery of breast cancer gene produces clues but no answers. In New York Times, pp. C3. Marx, J. (1997). Possible function found for breast cancer genes. Science 276, 531-532. Marx, J. (1996). A second breast cancer susceptibility gene is found [editorial]. Science 271, 30-31. Reviews on p53 and Breast Cancer Risk Barnes, D. M., and Camplejohn, R. S. (1996). P53, apoptosis, and breast cancer. Journal of Mammary Gland Biology and Neoplasia 1, 163-175. Begley, S. (1996). The cancer killer. In Newsweek, pp. 42-47. Culotta, E., and Koshland Jr., D. E. (1993). p53 sweeps through cancer research. Science 262, 1958-1961. Harris, C. C. (1996). p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environmental Health Perspectives 104, 435-439. Hayes, D. (1994). Tumor markers for breast cancer; current utilities and future prospects. Hematology/Oncology Clinics of North America 8, 485-506. Semenza, J. C., and Weasel, L. H. (1997). Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environmental Health Perspectives 105(Suppl 1), 155-163. Sun, X. F., Johannsson, O., Hakansson, S., Sellberg, G., Nordenskjold, B., Olsson, H., and Borg, A. (1996). A novel p53 germline alteration identified in a late onset breast cancer kindred. Oncogene 13, 407-411. BRCA1, and BRCA2; Breast Cancer Susceptibility Genes (1995). Second isolated breast cancer gene may aid research. In Ithaca Journal (Ithaca. Bonilla, F., Provencio, M., and Cubedo, R. (1996). BRCA1 and BRCA2: Breast and ovarian cancer susceptibility genes.

2 of 5

2/20/10 4:45 PM

Genetics and Breast Cancer Risk

http://envirocancer.cornell.edu/Bibliography/Genetics/bib.genetic.cfm

Oncologia 19, 33-39. Chen, Y., Chen, P., Riley, D. J., Lee, W., Allred, D. C., and Osborne, C. K. (1996). Location of BRCA1 in human breast and ovarian cancer cells. Science 272, 125-126. Chen, Y., Farmer, A. A., Chen, C. F., Jones, D. C., Chen, P. L., and Lee, W. H. (1996). BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in cell cycle-dependent manner. Cancer Research 56, 3168-3172. Collins, F. S. (1996). BRCA1 - lots of mutations, lots of dilemmas [editorial]. New England Journal of Medicine 334, 186-188. Couch, F. J., DeShano, M. L., Blackwood, M. A., Calzone, K., Stopper, J., Campeau, L., Ganguly, A., Rebbeck, T., and Weber, B. L. (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. New England Journal of Medicine 336, 1409-1415. Durocher, F., Tonin, P., Shattuck-Eidens, D., Skolnick, M., and Narod, S. A. (1996). Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. Journal of Medical Genetics 33, 814-819. Eeles, R. (1996). Testing for the breast cancer predisposition gene, BRCA1. British Medical Journal 313, 572-573. FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P. E., C., Sgroi, D. C., Smith, B. L., Younger, J. W., Garber, J. E., Duda, R. B., Mayzel, K. A., Isselbacher, K. J., Friend, S. H., and Haber, D. A. (1996). Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. New England Journal of Medicine 334, 143-149. Gayther, S. A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, A. J., Stratton, M. R., and Easton, D. (1997). Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature Genetics 15, 103 - 105. Healy, B. (1997). BRCA Genes-Bookmaking, fortunetelling, and medical care (editorial). New England Journal of Medicine 336, 1448-1449. Kolata, G. (1996). Discovery of breast cancer gene produces clues but no answers. In New York Times (New York City, pp. C3. Krainer, M., Silva-Arrrieta, S., FitzGerald, M. G., Shimada, A., Ishioka, C., Kanamaru, R., MacDonald, D. J., Unsal, H., Finkelstein, D. M., Bowcock, A., Isselbacher, K. J., and Haber, D. A. (1997). Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. New England Journal of Medicine 336, 1416-1421. Langston, A. A., Malone, K. E., Thompson, J. D., Daling, J. R., and Ostrander, E. A. (1996). BRCA1 mutations in a population-based sample of young women with breast cancer. New England Journal of Medicine 334, 137-142. Marx, J. (1997). Possible function found for breast cancer genes. Science 276, 531-532. Marx, J. (271). A second breast cancer susceptibility gene is found [editorial]. Science 271, 30-31. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Grye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, D., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71. Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., Goldgar, D., Ostrer, H., and Offit, K. (1996). The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genetics 14, 188-190. Ostorio, A., Robledo, M., San Roman, J. M., Albertos, J., Lobo, F., Gallego, J., and Benitez, J. (1996). Molecular analysis of BRCA1 gene in fifteen Spanish families with breast and or ovarian cancer. Oncologia 19, 60-64. Roa, B. B., Boyd, A. A., Volcik, K., and Richards, C. S. (1996). Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genetics 14, 185-187. Rubin, S. C., I., B., Behbakht, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., Berchuck, A., Muto, M. G., Garber, J. E., Weber, B. L., Lynch, H. T., and Boyd, J. (1996). Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. New England Journal of Medicine 335, 1413-1416. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. (1997). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265 -275.

3 of 5

2/20/10 4:45 PM

Genetics and Breast Cancer Risk

http://envirocancer.cornell.edu/Bibliography/Genetics/bib.genetic.cfm

Scully, R., Ganesan, S., Brown, M., De Caprio, J. A., Cannistra, S. A., and Feunteun, J. (1996). Location of BRCA1 in human breast and ovarian cancer cells. Science 272, 123-124. Sharan, S. K., Morimatus, M., Albrecht, U., Lim, S.-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA1. Nature 386, 804-810. Shyam, S. K., Morimatsu, M., Albrecht, U., Lim, D.-S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature 386, 804 810. Spillman, M. A., and Bowcock, A. M. (1996). BRCA1 and BRCA1 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 13, 1639-1645. Stratton, J. F., Gayther, S. A., Russell, P., Dearden, J., Gore, M., Blake, P., Easton, D., and Ponder, B. A. J. (1997). Contribution of BRCA1 mutations to ovarian cancer. New England Journal of Medicine 336, 1125-1130. Stratton, M. R. (1996). Recent advances in understanding of genetic susceptibility to breast cancer. Human Molecular Genetics 5, 1515-1519. Struewing, J. P., Hartge, P., Wachholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., and Tucker, M. A. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine 336, 1401-1408. Thomas, J. E., Smith, M., Rubinfeld, B., Gutowski, M., Beckmann, R. P., and Polakis, P. (1996). Subcellular localization and analysis of apparent 180 kDa and 220 kDa proteins of the breast cancer susceptibility gene, BRCA1. Journal of Biochemical Chemistry 271, 28630 - 28635. Human Studies on BRCA Mutations and Breast Cancer Risk Couch, F. J., DeShano, M. L., Blackwood, M. A., Calzone, K., Stopper, J., Campeau, L., Ganguly, A., Rebbeck, T., and Weber, B. L. (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. New England Journal of Medicine 336, 1409-1415. Durocher, F., Tonin, P., Shattuck-Eidens, D., Skolnick, M., and Narod, S. A. (1996). Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites. Journal of Medical Genetics 33, 814-819. FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P. E., C., Sgroi, D. C., Smith, B. L., Younger, J. W., Garber, J. E., Duda, R. B., Mayzel, K. A., Isselbacher, K. J., Friend, S. H., and Haber, D. A. (1996). Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. New England Journal of Medicine 334, 143-149. Gayther, S. A., Mangion, J., Russell, P., Seal, S., Barfoot, R., Ponder, A. J., Stratton, M. R., and Easton, D. (1997). Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nature Genetics 15, 103 - 105. Krainer, M., Silva-Arrrieta, S., FitzGerald, M. G., Shimada, A., Ishioka, C., Kanamaru, R., MacDonald, D. J., Unsal, H., Finkelstein, D. M., Bowcock, A., Isselbacher, K. J., and Haber, D. A. (1997). Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. New England Journal of Medicine 336, 1416-1421. Langston, A. A., Malone, K. E., Thompson, J. D., Daling, J. R., and Ostrander, E. A. (1996). BRCA1 mutations in a population-based sample of young women with breast cancer. New England Journal of Medicine 334, 137-142. Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., Goldgar, D., Ostrer, H., and Offit, K. (1996). The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genetics 14, 188-190. Ostorio, A., Robledo, M., San Roman, J. M., Albertos, J., Lobo, F., Gallego, J., and Benitez, J. (1996). Molecular analysis of BRCA1 gene in fifteen Spanish families with breast and or ovarian cancer. Oncologia 19, 60-64. Roa, B. B., Boyd, A. A., Volcik, K., and Richards, C. S. (1996). Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genetics 14, 185-187. Rubin, S. C., I., B., Behbakht, K., Takahashi, H., Morgan, M. A., LiVolsi, V. A., Berchuck, A., Muto, M. G., Garber, J. E., Weber, B. L., Lynch, H. T., and Boyd, J. (1996). Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. New England Journal of Medicine 335, 1413-1416. Struewing, J. P., Hartge, P., Wachholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., and Tucker, M. A. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of medicine 336, 1401-1408.

4 of 5

2/20/10 4:45 PM

Genetics and Breast Cancer Risk

http://envirocancer.cornell.edu/Bibliography/Genetics/bib.genetic.cfm

Commentaries and Editorials on Genetics and Breast Cancer Baram, M. (1997). The laws of genetics (commentary). Environmental Health Perspectives 105, 488-491. Collins, F. S. (1996). BRCA1 - lots of mutations, lots of dilemmas [editorial]. New England Journal of Medicine 334, 186-188. Eeles, R. (1996). Testing for the breast cancer predisposition gene, BRCA1. British Medical Journal 313, 572-573. Hoffman, M. (1996). Desperately seeking BRCA1 [editorial]. American Scientist 84, 535-536. Kahn, P. (1996). Coming to grips with genes and risk. Science 274, 496-498. Kolata, G. (1996). Discovery of breast cancer gene produces clues but no answers. In New York Times (New York City, pp. C3. Ponder, B. (1997). Genetic testing for cancer risk. Science 278, 1050-1054. New Breast Cancer Tumor Suppressor Genes (1996). Slow gene linked to breast cancer. Science 274, 1309. Lewin, D. I. (1997). Technique uncovers new gene linked to human breast cancer. The Journal of NIH Research 9, 42. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947. Li, L., Li, X., Francke, U., and Cohen, S. N. (1997). The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell 88, 143-154. Pennisi, E. (1997). New tumor suppressor found twice (news). Science 275, 1876-1878. Travis, J. (1997). Double knockout lands a breast cancer gene. Science News 151, 37. Environmental Carinogenesis and Molecular Epidemiology Albertini, R. J., Nicklas, J. A., and O'Neill, J. P. (1996). Future research directions for evaluating human genetic and cancer risk from environmental exposures. Environmental Health Perspectives 104(Suppl 3), 503-510. Hanawalt, P. C. (1996). Role of transcription-coupled DNA repair in susceptibility to environmental carcinogenesis. Environmental Health Perspectives 104, 547-551. Perera, F. P. (1996). Molecular epidemiology: insights into cancer susceptibility, risk assessment and prevention. Journal of the National Cancer Institute 88, 496-509. Perera, F. P., Mooney, L. A., Dickey, C. P., Santella, R. M., Bell, D., Blaner, W., Tang, D., and Whyatt, R. M. (1996). Molecular epidemiology in environmental carcinogenesis. Environmental Health Perspectives 104(Suppl 3), 441-443. Semenza, J. C., and Weasel, L. H. (1997). Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker. Environmental Health Perspectives 105(Suppl 1), 155-163. Back to the top

Prepared by Suzanne M. Snedeker, Ph.D., BCERF ResearchProject Leader

We will make every effort to update this bibliography. If you have comments on this bibliography, or have a suggestion of a reference you would like us to review for inclusion in the bibliography, please send this information via email to: [email protected] Last Update 05.06.03 © 2009 Cornell University Program on Breast Cancer and Environmental Risk Factors Cornell University, College of Veterinary Medicine Vet Box 31, Ithaca, NY 14853-6401 Phone: 607.254.2893; Fax: 607.254.4730 Email: [email protected] We comply with the HONcode standard for trustworthy health information: Verify here.

5 of 5

2/20/10 4:45 PM